Bone Cancer (Osteosarcoma) in Dogs

Published on
Last updated on
3 min read

Key takeaways


Osteosarcoma is the formation of a malignant tumor in the bones. It is a highly metastatic cancer with a median survival rate of 2-4 months without treatment and 8-12 months with treatment. 

  • This is the most common type of bone cancer in dogs and is most prominent in large breeds and older pets
  • The symptoms of osteosarcoma include lameness, bone pain, swelling, limb asymmetry, and fragile bones (breaking with minimal trauma)
  • Diagnostics include x rays, bone scans, biopsies, urinalysis, and blood work
  • Treatment involves surgical removal of the tumor, generally through amputation where possible, and chemotherapy
  • Radiation as well as anti inflammatories and pain management are palliative care options
  • Prognosis is very poor and treatments are often used to minimize pain and improve comfort for the dog
Are you concerned?

Connect with a vet to get more information about your pet’s health.

Book an online vet

A closer look: Bone Cancer (Osteosarcoma) in Dogs


Osteosarcoma primarily is found in the limbs but can rarely affect bones in the skull, pelvis, or spine.

The prognosis for osteosarcoma is very poor. Even with treatment, the median survival time is under one year. Without treatment, survival time is between two and four months.

Connect with a vet to get more information

With verified licenses and excellent reviews from pet parents like you for this type of condition

Risk factors


Osteosarcoma is not the only type of cancer to affect the bones. Secondary tumors (metastasis) may form in the bones/marrow.

Bone cancer is more common in large breeds (50+ pounds) and is in dogs between 18-24 months of age and dogs over the age of 7. It is most commonly diagnosed in dogs between the ages of 6-8. Strong breed predispositions suggest a genetic component.

In rottweilers, spaying or neutering at an early age may contribute to a predisposition.

Prior radiation therapy for other cancers may predispose dogs to developing osteosarcoma.

Possible causes


The cause of osteosarcoma is mostly unknown. Osteosarcoma may develop at the site of previously healed fractures or infections (osteomyelitis).

Main symptoms


Testing and diagnosis


After a physical examination and medical history, a number of tests can confirm osteosarcoma:

  • Diagnostic imaging (x ray, ultrasound)
  • Biopsy
  • Blood analysis
  • Urinalysis
  • Bone scan

Steps to Recovery


Once osteosarcoma is confirmed, treatment can involve a number of options. In cases of osteosarcoma in a limb, amputation is often the first course of treatment, but limb-sparing options are also available. Chemotherapy is often performed in conjunction with surgery. Radiation is used as a method to minimize pain and spread of the tumor. Other methods including pain treatment, activity modifications, and anti-inflammatories can be used to minimize symptoms.

Immunotherapy options are currently under investigation.

Osteosarcoma is highly metastatic and most often fatal. Treatment can extend the life expectancy (2-4 months without treatment vs. 8-12 months with) but most care is palliative and managing symptoms.

Prevention


The cause of osteosarcoma is not known and due to this, there is little that can be done to prevent its formation. It is recommended that any limb weakness or inflammation is addressed promptly by a vet so early cases of the sarcoma can be identified and treated rapidly. Osteosarcoma is not contagious.

Is Bone Cancer (Osteosarcoma) in Dogs common?


Osteosarcoma is the most common bone cancer in dogs.

Typical Treatment


  • Surgery
  • Chemotherapy
  • Palliative care
  • Radiation

References


Bone Tumors in Dogs and Cats
Joseph Harari, , MS, DVM, DACVS - Writing for Merck Veterinary Manual
Osteosarcoma in Dogs
Dr. Jeffrey Philibert - Writing for PetPlace
Osteosarcoma (Bone Cancer) in Dogs
Lauren Jones, VMD - Writing for PetMD
Osteosarcoma in Dogs
Wendy Brooks, DVM, DABVP - Writing for Veterinary Partner

Our editorial committee

Our medical review team is responsible for validating and maintaining the quality of our medical information.